$2.06
-0.07-3.23%
Pre-Market: 4:56 PM EDT
Comments
Loading...
CervoMed (CRVO) Forecast
NewsEarningsCervoMed (CRVO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCervoMed (NASDAQ:CRVO) Stock Quotes, Forecast and News Summary
CervoMed Stock (NASDAQ: CRVO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CervoMed (CRVO) stock?
You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.
Who are CervoMed (CRVO) competitors?
Other companies in CervoMed’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Evaxion Biotech (NASDAQ:EVAX) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for CervoMed (CRVO) stock?
CervoMed has a consensus price target of $38.75.
What is the current price for CervoMed (CRVO)?
The stock price for CervoMed (NASDAQ: CRVO) is $2.0611 last updated January 14, 2025 at 4:56 PM EST.
Does CervoMed (CRVO) pay a dividend?
There are no upcoming dividends for CervoMed.
When is CervoMed (NASDAQ:CRVO) reporting earnings?
CervoMed’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is CervoMed (CRVO) going to split?
There is no upcoming split for CervoMed.
What sector and industry does CervoMed (CRVO) operate in?
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.